Ketek Information

Ketek is a popular prescribed antibiotic used to treat serious bacterial respiratory infections in adults such as bronchitis and pneumonia. More than three million patients in the United States have been prescribed the drug, manufactured by Sanofi-Aventis, which first received approval from the Food and Drug Administration in April 2004.

However, concerns over the Ketek's safety began to rise recently when the FDA recommended that a black box warning be added to the drug label. The new warning highlights the increased risk of severe and potentially life-threatening liver damage. Ketek has been associated with 23 cases of serious liver injury, 12 cases of liver failure that led to four deaths, and at least 44 reported cases of less serious Ketek liver problems.

Some patients even had liver damage within the first couple days of Ketek treatment and few of those had other health problems that could have resulted in liver injury. The FDA and other experts have concluded that Ketek is consistently and clearly associated with liver failure and other life-threatening Ketek problems that may lead to serious injury and death.

As of right now, Sanofi-Aventis, is revising the warning label on the drug to reflect the increased risk of life-threatening Ketek problems and severe side effects including liver failure and liver death linked to Ketek use.

If you or a loved one has suffered serious injuries, illness or death from taking Ketek, you may be entitled to receive compensation including pain and anguish, medical bills, lost income capacity, and more. Contact us today to speak to an experienced and qualified Ketek attorney who can inform you of your legal rights and options.